|
|
|
|
12 April 2021
|
|
|
Research and Innovation
What's new
|
|
|
|
|
|
|
|
News Alerts
|
|
Coronavirus: Commission mobilises €123 million for research and innovation to combat the threat of variants
|
The Commission is mobilising €123 million from Horizon Europe, the new EU research and innovation programme, for urgent research into coronavirus variants. This first emergency funding under Horizon Europe adds to a range of EU-funded research and innovation actions to fight the coronavirus and contributes to the Commission's overall action to prevent, mitigate and respond to the impact of coronavirus variants, in line with the new European bio-defence preparedness plan HERA Incubator.
Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth said:
|
|
|
|
We continue to mobilise all means at our disposal to fight this pandemic and the challenges presented by coronavirus variants. We must use our combined strength to be prepared for the future, starting from the early detection of the variants to the organisation and coordination of clinical trials for new vaccines and treatments, while ensuring correct data collection and sharing at all stages.
|
|
|
|
|
|
|
|
Success stories
|
|
A new approach to studying ocean ecology
|
Science has long held that in the food chain, plants support animals. While this may be true on land, the EU-funded MixITiN project has shown that such a system isn’t applicable to our oceans. The project hopes that its findings will help to improve knowledge and thus broader education efforts on marine ecology, allowing citizens to gain a better understanding of the ocean’s great wonders.
|
|
|
|
|
|
|
|
|
Events
|
|
Protect our oceans: the challenge of Europe's global leadership
|
As one of the first contributions to the 2021-2030 United Nations Decade of Ocean Science for Sustainable Development, the European Conference will take place the week following the 2021 World Oceans Day, at a time when global ocean governance is at a critical juncture.
|
|
|
 |
 |
|
Date |
|
16/06/2021
|
|
 |
 |
|
Venue |
|
Online
|
|
|
|
|
|
Horizon magazine
|
|
Q&A: BioNTech vaccine is only ‘mRNA 1.0’. This is just the beginning, say co-founders
|
The successful development of mRNA vaccines for Covid-19 is ‘transformational’ and opens the doors to new types of vaccines for other infectious diseases as well as cancer, according to Dr Özlem Türeci and Dr Uğur Şahin, the co-founders of Germany’s BioNTech.
|
|
|
|
|
|
|
|
|